20. DVFK-JAHRESTAGUNG IN BRAUNSCHWEIG
Datum: 03.09.2016 Ort: Ärztehaus, An der Petrikirche 1, 38100 Braunschweig AKTUELLE KARDIOLOGIE & INTERESSANTE KASUISTIKEN PROGRAMM: 8.45 Eröffnung: S.H. Nguyen, Präsident DVFK / Helmstedt 8.50 Begrüßung: M. C. Renneberg, Vizepräsidentin der Ärztekammer Niedersachsen (ÄKN) und Vorsitzende der ÄKN Bezirksstelle Braunschweig 8.55 Einleitung: R. Engberding, Präsident VGAC/Wolfsburg I. Sitzung: Koronare Herzkrankheit Vorsitz: R. Engberding (Wolfsburg), W. Harringer (Braunschweig) 09:00 Stellenwert der Echokardiographie bei der KHK I.Kruck (Ludwigsburg) 09:20 Stellenwert des Kardialen MRT bei der KHK C. Graf (Berlin) 09:40 Intrakoronare Bildgebung und intrakoronare Messungen zur Verbesserung der Koronarintervention V. Klauss (München) 10:00 Arteriosklerose und Vorhofflimmern: duale Plättchenhemmung und Triple Therapie 2016 H.-F. Vöhringer (Berlin) 10:20 Chirurgische Behandlungsmöglichkeiten der KHK 2016 W. Harringer (Braunschweig) II.Sitzung: Kooperation mit Vietnam Vorsitz: V. Klauss (München) / W. Fehske (Köln) 10:40 Entwicklung der Kardiologie in Vietnam D.D. Loi (Ha Noi) 11:00 Intervention bei angeborenen Herzfehlern in Vietnam P.M. Hung (Ha Noi) 11: 20 Pause III.Sitzung: Interessante Themen und Kasuistiken Vorsitz: B. Gerecke (Peine) / W-K. Diederich (Helmstedt) 11.50 Vorgehen beim asymptomatischen WPW-Syndrom J. Tebbenjohanns (Hildesheim) 12:10 Der "elektrische Sturm" : bestmögliche Behandlungskonzepte N.D. Quang (Köln) 12:30 Bewährte und neue medikamentöse Behandlung der Herzinsuffizienz B. Gerecke (Peine) 13:00 Schlusswort B. Gerecke (Peine) Im Anschluss weitere Diskussionen bei einem Imbiss REFERENTEN UND GÄSTE:
SPONSOREN DER TAGUNG: Bayer Vital GmbH (1000 €), Biotronik Vertriebs GmbH & Co. KG, Boehringer Ingelheim Pharma GmbH & Co.KG (500€), Daiichi-Sankyo Deutschland GmbH (1000 €), Medtronic GmbH (500 €), MSD Sharp & Dohme GmbH (500€), Novartis Pharma GmbH (750 €), SERVIER Deutschland GmbH (500 €)
0 Comments
Cardiovascular Conference Central expand Eighth
4 - 5 December 2015 Hotel Saigon-Dalat, Dalat City, Lam Dong Province Organization: Vietnam National Heart Association Heart Association Thua Thien Hue Heart Association Khanh Hoa In cooperation with Deutsch-Vietnamesischer Förderkreis für Kardiologie e.V. (DVFK)/German Vietnamese Association of Cardiology and Vietnamese German Academy for Science and Education in Cardiology and Cardiovascular Surgery (VGAC), Lectures: Endovascular closure of the left atrial appendage - Why and How Dr. Christian Glatthor, Cardiovascular Center Ravensburg, Germany Intracoronary imaging and physiology for improvement of coronary interventions Prof. Dr. Volker Klauss, Cardiology Munich City Centre, Munich, Germany Modern antithrombotic treatment strategies in coronary heart disease and stroke prevention Prof. Dr. Florian Krötz, Clinic Starnberg, Department of Cardiology, 82319 Starnberg, Germany Electrical storm: treatment strategies Dr. Lutz Lichtenberg, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Cologne, Germany LAA-occlusion: Indication, devices und techniques of implantation Dr. Dinh Quang Nguyen, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Cologne, Germany Atrial fibrillation: differential use of ablation techniques Dr. Dinh Quang Nguyen, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Cologne, Germany Non-invasive positive pressure ventilation for the treatment of chronic obstructive pulmonary disease (COPD) Prof. Dr. Si Huyen Nguyen, Vietnamese German Faculty of Medicine at Pham Ngoc Thach University of Medicine HCMC, HELIOS St. Marienberg Hospital Helmstedt, Academic Hospital of the Otto-von-Guericke University Magdeburg, Germany Intracoronary assessment – OCT or IVUS? Dr. Klaus Schlotterbeck, FESC, MBA, Cardiovascular Center Ravensburg, Germany New Drugs in CVD Therapy - Update 2015 Dr. Alexander Trompler, Cardiovascular Center Ravensburg, Germany Berlin Myocardial Infarction Registry (BMIR) - managing the Acute Coronary Syndrome (ACS) at the city of Berlin Prof. Dr. Hans-F. Voehringer, DRK Clinics Berlin, Germany Aortic stenosis: Noninvasive assessment - interventional therapy PD Dr. Werner Zwehl, 80638 München, Germany FACULTY: Dr. Christian Glatthor, Cardiovascular Center Ravensburg, Germany Prof. Dr. Volker Klauss, Cardiology Munich City Centre, Munich, Germany Prof. Dr. Florian Krötz, Clinic Starnberg, Department of Cardiology, 82319 Starnberg, Germany Dr. Lutz Lichtenberg, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany Dr. Dinh Quang Nguyen, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany Prof. Dr. Si Huyen Nguyen, Vietnamese German Faculty of Medicine at Pham Ngoc Thach University of Medicine HCMC, HELIOS St. Marienberg Hospital Helmstedt, Academic Hospital of the Otto-von-Guericke University Magdeburg, Germany Dr. Klaus Schlotterbeck, FESC, MBA, Cardiovascular Center Ravensburg, Germany Dr. Alexander Trompler, Cardiovascular Center Ravensburg, Germany Prof. Dr. Hans-F. Voehringer, DRK Clinics Berlin, Germany PD Dr. Werner Zwehl, 80638 München, Germany VIETNAMESE GERMAN SCIENTIFIC SYMPOSIUM
NHA TRANG 01.12.2015 VENUE: KHANH HOA HOSPITAL TIME: 14:00 – 17:00 Organization: Vietnamese Heart Association of Khanh Hoa General Hospital KHANH HOA Nha Trang In Cooperation with
Lectures: Endovascular closure of the left atrial appendage - Why and How Dr. Christian Glatthor, Cardiovascular Center Ravensburg, Germany Intracoronary imaging and physiology for improvement of coronary interventions Prof. Dr. Volker Klauss, Cardiology Munich City Centre, Munich, Germany Modern antithrombotic treatment strategies in coronary heart disease and stroke prevention Prof. Dr. Florian Krötz, Clinic Starnberg, Department of Cardiology, 82319 Starnberg, Germany Electrical storm: treatment strategies Dr. Lutz Lichtenberg, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Cologne, Germany Atrial fibrillation: differential use of ablation techniques Dr. Dinh Quang Nguyen, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Cologne, Germany Non-invasive positive pressure ventilation for the treatment of chronic obstructive pulmonary disease (COPD) Prof. Dr. Si Huyen Nguyen, Vietnamese German Faculty of Medicine at Pham Ngoc Thach University of Medicine HCMC, HELIOS St. Marienberg Hospital Helmstedt, Academic Hospital of the Otto-von-Guericke University Magdeburg, Germany Intracoronary assessment – OCT or IVUS? Dr. Klaus Schlotterbeck, FESC, MBA, Cardiovascular Center Ravensburg, Germany New Drugs in CVD Therapy - Update 2015 Dr. Alexander Trompler, Cardiovascular Center Ravensburg, Germany Berlin Myocardial Infarction Registry (BMIR) - managing the Acute Coronary Syndrome (ACS) at the city of Berlin Prof. Dr. Hans-F. Voehringer, DRK Clinics Berlin, Germany Aortic stenosis: Noninvasive assessment - interventional therapy PD Dr Werner Zwehl, 80638 München, Germany FACULTY: Dr. Christian Glatthor, Cardiovascular Center Ravensburg, Germany Prof. Dr. Volker Klauss, Cardiology Munich City Centre, Munich, Germany Prof. Dr. Florian Krötz, Clinic Starnberg, Department of Cardiology, 82319 Starnberg, Germany Dr. Lutz Lichtenberg, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany Dr. Dinh Quang Nguyen, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany Prof. Dr. Si Huyen Nguyen, Vietnamese German Faculty of Medicine at Pham Ngoc Thach University of Medicine HCMC, HELIOS St. Marienberg Hospital Helmstedt, Academic Hospital of the Otto-von-Guericke University Magdeburg, Germany Dr. Klaus Schlotterbeck, FESC, MBA, Cardiovascular Center Ravensburg, Germany Dr. Alexander Trompler, Cardiovascular Center Ravensburg, Germany Prof. Dr. Hans-F. Voehringer, DRK Clinics Berlin, Germany PD Dr Werner Zwehl, 80638 München, Germany .15. VIETNAMESE GERMAN HEART DAYS
Ho Chi Minh City 29.11.2015 Organization: Vietnamese Heart Association of Ho Chi Minh City in Cooperation with
Vietnamese German Scientific Symposium Lectures: Endovascular closure of the left atrial appendage - Why and How Dr. Christian Glatthor, Cardiovascular Center Ravensburg, Germany Since more than a decade there is growing experience in interventions for prophylaxis of cardiogenic thromboembolic events. Based on randomized date, notably PROTECT-AF and PREVAIL, the technical development of mainly two devices for transvenous transseptal left atrial appendage occlusion (LAAO) has reached a satisfactory state which is supplemtentary documented in a lot of registry data. Patients with non valvular atrial fibrillation who are not suitable for medical anticoagulation nowadays should be treated with one of the available LAA-closure devices. After some related initial hostile event experiences, the implantation procedure has developed and can be looked upon as safe and effective. The special design of an elaborate and thorough training phase together with a an acceptable learning curve makes that particular procedure become more and more indispensable part of daily practice. Intracoronary imaging and physiology for improvement of coronary interventions Prof. Dr. Volker Klauss, Cardiology Munich City Centre, Munich, Germany The decision for interventional treatment of a coronary lesion should be based on symptoms and prove of ischemia. However, in clinical practice, stenoses are often treated depending on the angiographic image, because symptoms are not clear and tests for ischemia have not been performed or the tests are inconclusive. By means of intracoronary pressure measurements (i.e. determination of fractional flow reserve – FFR, or instantaneous wave-free ratio - iFR) the hemodynamic relevance of a coronary stenoses can be determined during coronary angiography especially in intermediate lesions and thus the decision to treat or not to treat is based on an objective test of ischemia. Regarding coronary morphology, angiography is the standard for imaging of the coronary tree. However, this technique has limitations. Intravascular ultrasound (IVUS) allows a cross-sectional view of the coronary arteries. IVUS may help to diagnose and assess stent underexpansion and malapposition, and to guide interventions in complex cases. A new modality based on infrared light is the optical coherence tomography (OCT) with a resolution better than IVUS. It is now used for evaluation of new stent technologies i.e. bioabsorbable scaffolds. Modern antithrombotic treatment strategies in coronary heart disease and stroke prevention Prof. Dr. Florian Krötz, Clinic Starnberg, Department of Cardiology, 82319 Starnberg, Germany New oral anticoagulants and modern potent antiplatelet drugs offer a wide variety of therapeutic antithrombotic treatment strategies for acute coronary syndromes, coronary interventions and patients with atrial fibrillation. However, use of these drugs – especially when they are being combined - may not only bring about advantages but also impose increased bleeding risks, depending of patient comorbidities. In addition, depending on coronary intervention and clinical setting, the duration of antithrombotic treatment is a continuous topic of debate. Patricularly the need for a so called “triple therapy”, traditionally referred to as a combination of ASA, clopidogrel and warfarin, increases bleeding risk and may in many cases not be performed using the newer antiplatelet agents. Although data on triple therapy are scarce, in 2014, the European society of cardiology for the first time has published recommendations on which drugs may be combined in patients with recent stent implantation and atrial fibrillation. The presentation will discuss current European recommendations on use of antiplatelet and anticoagulant drugs with respect to indication, cardiovascular outcomes and bleeding risk and introduce the current evidence on these drugs. Electrical storm: treatment strategies Dr. Lutz Lichtenberg, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Cologne, Germany Electrical storm is an increasingly common and life-threatening syndrome that is defined by 3 or more sustained episodes of ventricular tachycardia, ventricular fibrillation, or appropriate shocks from an implantable cardioverter-defibrillator within 24 hours. The clinical presentation can be dramatic. Electrical storm can manifest itself during acute myocardial infarction and in patients who have structural heart disease, an implantable cardioverter-defibrillator, or an inherited arrhythmic syndrome. The presence or absence of structural heart disease and the electrocardiographic morphology of the presenting arrhythmia can provide important diagnostic clues into the mechanism of electrical storm. Electrical storm typically has a poor outcome. The effective management of electrical storm requires an understanding of arrhythmia mechanisms, therapeutic options, device programming, and indications for radiofrequency catheter ablation. Initial management involves determining and correcting the underlying ischemia, electrolyte imbalances, or other causative factors. Amiodarone and β-blockers, especially propranolol, effectively resolve arrhythmias in most patients. Nonpharmacologic treatment, including radiofrequency ablation, can control electrical storm in drug-refractory patients. Patients who have implantable cardioverter-defibrillators can present with multiple shocks and may require drug therapy and device reprogramming. After the acute phase of electrical storm, the treatment focus should shift toward maximizing heart-failure therapy, performing revascularization, and preventing subsequent ventricular arrhythmias. Atrial fibrillation: differential use of ablation techniques Dr. Dinh Quang Nguyen, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Cologne, Germany The impact of atrial fibrillation on the healthcare systems is overwhelming, due to its independent association with death, systemic thromboembolism, impaired quality of life and hospitalizations. Catheter ablation is the only treatment thus far demonstrated capable of achieving cure in a substantial proportion of patients. Pulmonary vein antrum isolation (PVAI) is the cornerstone of current atrial fibrillation ablation techniques, with the greatest efficacy as a stand-alone procedure in patients with paroxysmal atrial fibrillation. Use of general anesthesia, open-irrigated ablation catheters, “single shot devices” (Cryo balloon, Laser balloon, PVAC) and maintenance of periprocedural therapeutic warfarin has been demonstrated to increase the safety and effectiveness of PVAI. A more extensive ablation approach extending to the entire left atrial posterior wall and to complex fractionated electrograms (CFAEs) is warranted in nonparoxysmal atrial fibrillation patients, in whom nonpulmonary vein trigger sites are frequently identified. Up to one-third of these patients experiencing atrial fibrillation recurrence after ablation have evidence of triggers from extra pulmonary locations (SVC, CS, left atrial appendage). Isolation of this structure can improve the long-term success rate. In recent years, in addition to the development of ablation techniques to increase the success rate, outcomes of atrial fibrillation treatment trials have been reconsidered. This presentation will summarize the state-of-the art techniques for atrial fibrillation ablation, and will discuss the contribution of ongoing studies to the future of atrial fibrillation ablation. Non-invasive positive pressure ventilation for the treatment of chronic obstructive pulmonary disease (COPD) Prof. Dr. Si Huyen Nguyen, Vietnamese German Faculty of Medicine at Pham Ngoc Thach University of Medicine HCMC, HELIOS St. Marienberg Hospital Helmstedt, Academic Hospital of the Otto-von-Guericke University Magdeburg, Germany The non-invasive ventilation (NIV) has been established for about 20 years as a successful treatment method for acute respiratory insufficiency (ARI), as home ventilation it has been used in the last 10 years by hypercapnic COPD patients increasingly. NIV reduced hypercapnic ARF, the rate of tube-associated pneumonia, duration of hospital stay and in-hospital mortality. If possible, it should be applied preferably for ARI to avoid complications of mechanical ventilation. NIV has also proved to be a very useful therapeutic measure during cardiac pulmonary edema and for weaning from invasive long-term ventilation. A persistent hypercapnia for medically treated patients with COPD is a manifest sign of the failure of the respiratory pump and thus indicates a poor prognosis of the disease. It is also regarded as a criterion for initiating nocturnal home ventilation with a non-invasive, pressure-controlled ventilation (NPPV). This measure is primarily to improve the quality of life. In a recently published study by Köhnlein et al a relevant life extension by NPPV has now been documented in patients with a chronic failure of the respiratory pump in COPD for the first time. The pathophysiology of COPD, indications and contraindications for NIV in ARI and nocturnal home ventilation, techniques and practical application of non-invasive ventilation are presented. Intracoronary assessment – OCT or IVUS? Dr. Klaus Schlotterbeck, FESC, MBA, Cardiovascular Center Ravensburg, Germany The gold standard for diagnostic imaging of the coronary arteries is still the angiography. Many limitations of this technique are known, so advancements in technology has been developed. Intravascular ultrasound was the first intravascular imaging technique developed to overcome the limitations of angiography. The use of intravascular ultrasound (IVUS) has enabled a transmural in-vivo imaging of the coronary arteries while creating cross-sectional images of the vessel wall. The role of IVUS is to assess stent underexpansion and malapposition, to identify coronary plaques with potential rupture, to plan intervention in complex cases, identify significant left main stem stenosis. The spectral analysis, derived from radiofrequency (RF) data enables more precise analysis of the plaque composition and plaque type. In the PROSPECT study, tissue characterization of plaques had a predominant role and a positive association was found between specific tissue types and clinical events. A newer modality based on infrared light is the optical coherence tomography (OCT). With a resolution of 10-20 µm, which is better than IVUS, this method provides intraluminal and extraluminal imaging of the vessels. OCT gives in vivo imaging of coronary stents with the ODESSA and LEADERS trials pioneering OCT in multicenter, randomized clinical settings. Based on OCT it is able to distinguish between different tissue types, such as fibrous, lipid rich, necrotic or calcified tissue. OCT helps to assess patients with acute coronary syndrome with insights into plaque nature, rupture and progression. It also has been established as a gold standard for stent evaluation. However it is currently not capable of providing the operator with functional information to assess e.g. the haemodynamic relevance of stenosis. A number of research have successfully combined OCT with an ultrasonic transducer allowing the combination of high-resolution of OCT in the near field with the penetration depth if IVUS to visualise the complete plaque as well as to assess plaque burden. Conclusion: IVUS and OCT have an important but different role in intravascular imaging. Promising concepts for quantitative tissue characterization and combination of both techniques might further improve the diagnostic capabilities in the future. New Drugs in CVD Therapy - Update 2015 Dr. Alexander Trompler, Cardiovascular Center Ravensburg, Germany An update on 2014/2015 Evolution of CVD Drug Therapy will be given. Among others to be covered: Angiotensin receptor-neprilysin inhibitor Oral Anticoagulants including reversal agents Lipid Lowering Drugs including PCSK9 inhibitors Duration of dual antiplatelet therapy after MI Berlin Myocardial Infarction Registry (BMIR) - managing the Acute Coronary Syndrome (ACS) at the city of Berlin Prof. Dr. Hans-F. Voehringer, DRK Clinics Berlin, Germany The BMIR is an ongoing joint registry of hospitals within the metropolitan area of Berlin, prospectively collecting data on treatment and outcome of patients with myocardial infarction since 1999. Judging hospitals according to their quality of care is one approach to improve hospital performance. It is the aim of the presented data showing the feasibility of comparing the quality of care between departments of cardiology in different hospitals addressing the problems of random variation and differences in patients’ mix. The analysis is a cross-sectional interhospital comparison of more than 36 000 ACS patients (end of 2014) within different time intervals. The patients were admitted into 22 different hospitals of Berlin with PCI facilities in order of regular monitoring. Data were collected on demography, concomitant diseases, treatment strategies, and outcome measures. In the cross-sectional as well as in the longitudinal comparison there were large interhospital differences in crude hospital mortality rates. After Bayesian shrinkage and adjustment for the differences in patient mix, the range in hospital mortality was reduced in the cross-sectional as well as in the longitudinal comparison with no significant differences between hospitals. Adjusted mortality rates were 8.9 % in 2007/08, 8.7 % in 2009/10, and 8.5 % in 2011/12, respectively (p = 0.609). The analysis demonstrates that the naïve comparison of hospitals by crude means may be unfair and misleading. A statistical analysis that makes population differences and random effects into account may result in different conclusions and may show stable results for average-size German city hospitals, if data are pooled over 3 years. Aortic stenosis: Noninvasive assessment - interventional therapy PD Dr Werner Zwehl, 80638 München, Germany FACULTY: Dr. Christian Glatthor, Cardiovascular Center Ravensburg, Germany Prof. Dr. Volker Klauss, Cardiology Munich City Centre, Munich, Germany Prof. Dr. Florian Krötz, Clinic Starnberg, Department of Cardiology, 82319 Starnberg, Germany Dr. Lutz Lichtenberg, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany Dr. Dinh Quang Nguyen, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany Prof. Dr. Si Huyen Nguyen, Vietnamese German Faculty of Medicine at Pham Ngoc Thach University of Medicine HCMC, HELIOS St. Marienberg Hospital Helmstedt, Academic Hospital of the Otto-von-Guericke University Magdeburg, Germany Dr. Klaus Schlotterbeck, FESC, MBA, Cardiovascular Center Ravensburg, Germany Dr. Alexander Trompler, Cardiovascular Center Ravensburg, Germany Prof. Dr. Hans-F. Voehringer, DRK Clinics Berlin, Germany PD Dr. Werner Zwehl, 80638 München, Germany Prof. Dr. Rolf Engberding 19. DVFK-JAHRESTAGUNG IN BRAUNSCHWEIG Datum: 05.09.2015 Ort: Ärztehaus, An der Petrikirche 1, 38100 Braunschweig AKTUELLE KARDIOLOGIE & INTERESSANTE KASUISTIKEN PROGRAMM: 8.45 Eröffnung: S.H. Nguyen, Präsident DVFK / Helmstedt 8.50 Begrüßung: M. Renneberg, Vorsitzende der Ärztekammer Niedersachsen Bezirksstelle Braunschweig 8.55 Einleitung: R. Engberding, Präsident VGAC/Wolfsburg I. Sitzung: Vorhofflimmern: Update 2015 Vorsitz: R. Engberding (Wolfsburg), V. Klauss (München) 09:00 Medikamentöse Therapie des Vorhofflimmerns B. Gerecke (Peine) 09:20 Ablationstherapie bei Vorhofflimmern R. Becker (Wolfsburg) 09:40 Der LAA-Verschluss J. Tebbenjohanns (Hildesheim) 10:10 Herzchirurgische Behandlung des Vorhofflimmerns W. Harringer (Braunschweig) 10:20 Antikoagulation bei Vorhofflimmern H. Vöhringer (Berlin) 10:40 Pause II. Sitzung: Der Myokardinfarkt aus anderen Blickwinkeln & Interessante Kasuistiken Vorsitz: G.D. Kneissl (Mainz), K-W. Diederich (Helmstedt) 11:00 Echokardiographie beim akuten Koronarsyndrom B. Du Quoc (Köln) 11:20 Myokardinfarkt: was sollen wir tun? C. Fleischmann (Wolfsburg) 11:40 Myokardinfarkt mit normalen Koronararterien B. Schneider (Lübeck) 12:00 Myokardinfarkt bei Kindern S. Kotthoff (Münster) 12:20 Interessante Kasuistik D.Q. Nguyen (Köln) 12:40 Schlusswort B. Gerecke im Anschluss gemeinsamer Imbiss und weitere Diskussion REFERENTEN UND GÄSTE:
Grußwort von Frau M. Renneberg, Vorsitzende der Ärztekammer Bezirksstelle Braunschweig Prof. Dr. R. Becker (Wolfsburg) Prof. Dr. J. Tebbenjohanns (Hildesheim) PD. Dr. W. Harringer (Braunschweig) Prof. Dr. H.-F- Vöhringer (Berlin) Dr. Birke Schneider (Lübeck) Dr. Bao Du Quoc (Köln) Dr. Stefan Kotthoff (Münster) Dr. Dinh Quang Nguyen (Köln) Mittagspause und Diskussionen EINLADUNG ZUR ERÖFFNUNGSFEIER DER 19. DVFK-JAHRESTAGUNG am 04. September 2015 Uhrzeit: 18:30 Uhr Ort: Restaurant Goldener Drache Hintern Brüdern 27-30, 38100 Braunschweig Tel. 0531 15630 PROGRAMM: 18:45 Uhr: Eröffnung Prof. Dr. Rolf Engberding / Wolfsburg Präsident der VGAC 19:00 Uhr: Unser Arbeitsbesuch an der Vietnamese German Faculty of Medicine (VGFM) in Ho Chi Minh City Jan Philipp Schneider, Institut für Funktionelle und Angewandte Anatomie, MHH 19:45 Uhr Schlusswort Dr. Birgit Gerecke/Peine 20:00- 22:30 Uhr Persönliche Gespräche, Erfahrungsaustausch, Beisammensein… beim gemeinsamen vietnamesischen Abendessen von li. nach re. Frau A. Schlotterbeck (Braunschweig), Prof. R. Engberding (Wolfsburg), Frau T.M.H. Nguyen (Helmstedt), Dr. J. Schneider (Hannover) Prof. DV Phuoc (HCMC), Prof. H.-F. Vöhringer (Berlin) VIETNAMESE GERMAN CONGRESS HOI NGHI DUC VIET NEW CHALLENGES IN CARDIOVASCULAR TECHNIQUES THÁCH THỨC MỚI VỀ KỸ THUẬT TIM MẠCH Venue/Địa điểm: Rex Hotel 141 Nguyen Hue St., Dist. 1, Ho Chi Minh City, Viet Nam Time/Thời gian: Sunday, 30th November 2014 8:30 – 15:15 Chairpersons: Prof. Dr. Dang Van Phuoc Prof. Dr. Volker Klauss PD Dr. Wolfgang Fehske Prof. Dr. Pham Nguyen Vinh Prof. Dr. Georg Dieter Kneissl Prof. Dr. Truong Quang Binh Organization:
in cooperation with:
Program/Chương trình: 08:30-08:40 GREETING CHÀO MỪNG HỘI NGHỊ Prof. Dr. Dang Van Phuoc Prof. Dr. Nguyen Si Huyen Prof. Dr. Pham Nguyen Vinh Session I: Clinical Cardiology Chairpersons: Prof. Volker Klauss/Prof. Dang Van Phuoc 08:40-09:00 Sport and arrhythmia Thể thao và Rối loạn nhịp Dr. Birgit Gerecke, MVZ Ambulatory Cardiac Centre Peine, Germany 09:00-09:20 Catheter ablation of atrial fibrillation: newest developments Đốt điện sinh lý trong rung nhĩ: Những tiến bộ mới Dr. Dinh Quang Nguyen, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany 09:20-09:40 Updated new guidelines in the treatment of hypertension Cập nhật khuyến cáo mới trong điều trị Tăng huyết áp Prof. Dang Van Phuoc, The president of Ho Chi Minh Cardiovascular Association, Viet Nam 09:40-10:00 Catheter ablation of ventricular tachyarrhythmias: epicardiac approach: when? how? Đốt điện sinh lý trong nhanh thất: Tiếp cận từ màng ngoài tim: Khi nào? Như thế nào? Dr. Dinh Quang Nguyen, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany 10:00-10:20 3-D-Echocardiography Siêu âm tim 3-D PD Dr. Wolfgang Fehske, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany TEA BREAK Session II: Clinical Cardiology & Echocardiography & Cardiac surgery Chairpersons: Prof. Dr. Georg-D. Kneissl/Prof. Pham Nguyen Vinh 10:35-10:55 Fixed dose combination therapy in the treatment of hypertension Phối hợp thuốc liều cố định trong điều trị Tăng huyết áp Prof. Truong Quang Binh, Vice-director of Ho Chi Minh Medical University, Viet Nam 10:55-11:15 Sleep-related breathing disorders and heart failure Rối loạn nhịp thở khi ngủ và suy tim Prof. Dr. Si Huyen Nguyen, Vietnamese German Faculty of Medicine at Pham Ngoc Thach University of Medicine HCMC, HELIOS St. Marienberg Hospital Helmstedt, Academic Hospital of the University Magdeburg, Germany 11:15-11:35 Clinically important drug interactions in cardiovascular therapy Những tương tác thuốc quan trọng trên lâm sàng trong điều trị bệnh tim mạch Prof. Dr. Hans-F. Voehringer, DRK Clinics Berlin, Germany 11:35-11:55 Current clinical practice in Europe for management of atrial fibrillation Thực hành lâm sàng trong điều trị rung nhĩ hiện nay tại Châu Âu Prof. Dr. Hans-F. Voehringer, DRK Clinics Berlin, Germany LUNCH BREAK Session III: Clinical Cardiology & Electrophysiology Chairpersons: PD Dr. Wolfgang Fehske/Prof. Truong Quang Binh 13:00-13:20 The “fibrotic atrial cardiomyopathie (FACM)” : new substrate for atrial fibrillation? Consequences for clinical practice? Bệnh cơ tim xơ hóa tâm nhĩ (FACM)”: Chất nền mới trong rung nhĩ ? Tầm quan trọng trong thực hành lâm sàng ? Dr. Dinh Quang Nguyen, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany 13:20-13:40 Stress echocardiography Siêu âm tim gắng sức PD Dr. Wolfgang Fehske, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany 13:40-14:00 Diabetes and DPP4 Đái tháo đường và DPP4 Prof. Pham Nguyen Vinh, Vice-president of Viet Nam Cardiovascular Association, Viet Nam 14:00-14:20 The net clinical benefit of dabigatran in stroke prevention: What have we learned from recent data? Lợi ích lâm sàng của dabigatran trong phòng ngừa đột quỵ: chúng ta học được gì từ các dữ liệu gần đây? Dr. Ho Huynh Quang Tri, HCM Heart Institude, Viet Nam 14:20-14:40 The aortic valve replacement through the skin Thay van động mạch chủ qua da Dr. Nguyen Huynh Khuong, Tam Duc Hospital, Viet Nam 14:40-15:00 Beyond angiography: modalities for assessment of coronary artery lesions Phương thức đánh giá tổn thương ĐM vành ngoài chụp mạch máu cản quang Prof. Dr. Volker Klauss, Cardiology Munich City Centre, Munich, Germany 15:20-15:30 Closing Remarks Faculty: PD Dr. Wolfgang Fehske, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany Dr. Birgit Gerecke, MVZ Ambulatory Cardiac Centre Peine, Germany Prof. Dr. Volker Klauss, Cardiology Munich City Centre, Munich, Germany Prof. Dr. Georg-Dieter Kneissl, Vietnamese German Faculty of Medicine at the Pham Ngoc Thach University of Medicine /HCM City, Johannes Gutenberg Universitätsmedizin Mainz, Germany Prof. Dr. Si Huyen Nguyen, Vietnamese German Faculty of Medicine at the Pham Ngoc Thach University of Medicine /HCM City, Academic Hospital HELIOS St. Marienberg Helmstedt, Germany Dr. Dinh Quang Nguyen, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany Prof. Dr. Hans-F. Voehringer, DRK Clinics Berlin, Germany Prof. Dang Van Phuoc, The president of Ho Chi Minh Cardiovascular Association, Viet Nam Prof. Pham Nguyen Vinh, Vice-president of Viet Nam Cardiovascular Association, Viet Nam Prof. Truong Quang Binh, Vice-director of Ho Chi Minh Medical University, Viet Nam Dr. Ho Huynh Quang Tri, HCM Heart Institude, Viet Nam Dr. Nguyen Huynh Khuong, Tam Duc Hospital, Viet Nam 4. Vietnamese German Scientific Symposium
Nha Trang, 26.11.2014 Venue: Khanh Hoa Hospital Time: 13:30 – 17:00 Organization: Vietnam Heart Association Khanh Hoa Community Hospital Khanh Hoa In Cooperation with
Lectures: Sport and arrhythmia Dr. Birgit Gerecke, MVZ Ambulatory Cardiac Centre Peine, Germany Sleep apnea and heart failure Prof. Dr. Si Huyen Nguyen, Vietnamese German Faculty of Medicine at Pham Ngoc Thach University of Medicine HCMC, HELIOS St. Marienberg Hospital Helmstedt, Academic Hospital of the University Magdeburg, Germany Diagnosis and treatment of pulmonary embolism: Role of echocardiography Prof. Dr. Si Huyen Nguyen, Vietnamese German Faculty of Medicine at Pham Ngoc Thach University of Medicine, HELIOS St. Marienberg Hospital Helmstedt, Academic Hospital of the University Magdeburg, Germany Clinically important drug interactions in cardiovascular therapy Prof. Dr. Hans-F. Voehringer, DRK Clinics Berlin, Germany Current clinical practice in Europe for management of atrial fibrillation Prof. Dr. Hans-F. Voehringer, DRK Clinics Berlin, Germany Beyond angiography: modalities for assessment of coronary artery lesions Prof. Dr. Volker Klauss, Cardiology Munich City Centre, Munich, Germany Faculty: Dr. Birgit Gerecke, MVZ Ambulatory Cardiac Centre Peine, Germany Prof. Dr. Volker Klauss, Cardiology Munich City Centre, Munich, Germany Prof. Dr. Si Huyen Nguyen, Vietnamese German Faculty of Medicine at the Pham Ngoc Thach University of Medicine /HCM City, Academic Hospital HELIOS St. Marienberg Helmstedt, Germany Prof. Dr. Hans-F. Voehringer, DRK Clinics Berlin, Germany Vietnamese German Scientific Symposium
Hanoi 22.11.2014 Venue: Vietnam National Heart Institute, Bach Mai University Hospital Time: 9:00 – 13:00 Organization: Vietnam National Heart Institute, Bach Mai University Hospital, Hanoi in cooperation with
Lectures: Sport and arrhythmia Dr. Birgit Gerecke, MVZ Ambulatory Cardiac Centre Peine, Germany Physical activity is an important factor to reduce cardiovascular risk. 2,5 – 5 hours a week of at least moderate intensity are recommended for adults of all ages in the guidelines for prevention of cardiovascular disease. But physical stress can also harm. There are about 0.2 – 3.0 cases of sudden cardiac death (SCD) in 100 000 young athletes (< 35 years) per year, 90 % of the share related to male athletes. Triathlon, american football and soccer have the most frequent number of arrhythmogenic deaths, highly recognized in the general public. The most important cause of SCD in athletes in a study of Maron (JAMA 2006) is hypertrophic cardiomyopathy (HCM) (36%), another 8 % had undetermined LV hypertrophy, possible HCM. Other and relying heart diseases were coronary artery anomalies (17%), myocarditis (6 %), ARVCM (4 %), channelopathies and other rare heart diseases. Only 3 % of the examined hearts of the athletes with SCD were normal. By screening programs the number of SCD in athletes can be reduced to less than the number in non-athletes (< 35 years) (about 1 / 100000 per year). The medical history has to include exertional problems, syncopes or near-syncopes, and a family history of sudden cardiac deaths under the age of 50 years in close relatives. Among other things cardiomyopathies, arrhythmogenic problems or congenital conditions should be inquired. Physical examinations of the athletes include heart murmurs, femoral pulses, stigmata for a marfan syndrome and brachial artery blood pressure. Associations as the FIFA recommend a precompetition medical assessment including a past and present medical history (e.g. infections), a physical and an orthopedic examination, an 12 lead resting ECG, an echocardiography and laboratory testing before eat testing the eligibility for competitive football. The challenge is to differentiate between the physiological changes of an athletes heart and the pathological features of a underlying heart disease. There is a high prevalence of ECG patterns (e.g. T- wave inversions, early repolarisation patterns) in athletes that have to be evaluated. There is also the need to advise athletes with different arrhythmias concerning participation in competitive sports. And there is a group of patients with acquired or congenital heart diseases that needs recommendations for participation in competitive or leisure sport activity. Catheter ablation of atrial fibrillation: newest developments Dr. Dinh Quang Nguyen, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany Atrial fibrillation (AF) is the most common arrhythmia and has gained increasingly more attention due to new treatment options, particularly catheter ablation. Growing experience with this technique and better AF suppression compared with antiarrhythmic medication have paved the way for its extended use and indication. At this point, it is recommended for symptomatic patients if antiarrhythmic drugs failed and in selected young symptomatic patients as first line therapy. We present an actualized overview of the different ablation techniques and the newest developments. The “fibrotic atrial cardiomyopathie (FACM)” : new substrate for atrial fibrillation? Consequences for clinical practice? Dr. Dinh Quang Nguyen, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany The atrial structure/substrate of patients with atrial fibrillation and clinically similar characteristics can present very differently, and also the 'phenotype' (i.e. paroxysmal, persistent, and long standing persistent) of the arrhythmia cannot comprehensively explain these differences. It was unclear why some patients stay in paroxysmal AF for decades, whereas other patients with the same characteristics progress to persistent AF within a few months. In this review, evidence is described that AF patients without apparent structural heart disease have a chronic fibrotic bi-atrial substrate. There is also evidence from intraoperatively obtained specimen analysis, post-mortem autopsy findings, electroanatomic mapping studies, and delayed enhancement-MRI investigations that a higher mean value of fibrosis is detected in patients with persistent vs. paroxysmal AF but that the variability in the extend of fibrosis is always very high with part of paroxysmal AF patients having massive fibrosis and part of persistent AF patients showing mild fibrosis. Catheter ablation of ventricular tachyarrhythmias: epicardiac approach: when? how? Dr. Dinh Quang Nguyen, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany Electrical storm (ES) is one of the most challenging clinical scenarios facing electrophysiologists, and in certain settings emergency ablation should be performed. The majority of ES occurs in patients with structural heart disease, predominantly coronary heart disease and nonischemic heart disease like right ventricular arrhythmogenic dysplasia and previous myocarditis as well as other cardiomyopathies. Implantable cardioverter-defibrillators (ICDs) are the first-line therapy in patients with ventricular tachycardia (VT) and structural heart disease. Recurrent VT episodes or ES are major problems in patients who receive an ICD after a spontaneous sustained VT. Catheter ablation has a high success rate in the acute setting in eliminating clinical VT. However, several factors make enodocardial catheter ablation of VT more difficult especially in advanced ischemic heart disease with heart failure and aneurysm. Frequently in nonischemic cardiomyopathies (NICM) there tends to be an epicardial and intramyocardial substrate where the critical VT zone can occasionally be epicardial or intramural in location. In some patients, an epicardial approach should be warranted first together with an endocardial approach or after failure of enodocardial ablation. 3-D-Echocardiography PD Dr. Wolfgang Fehske, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany Stressechocardiography PD Dr. Wolfgang Fehske, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany Sleep apnea and heart failure Prof. Dr. Si Huyen Nguyen, Vietnamese German Faculty of Medicine at Pham Ngoc Thach University of Medicine HCMC, HELIOS St. Marienberg Hospital Helmstedt, Academic Hospital of the University Magdeburg, Germany The prevalence of sleep-related breathing disorders both obstructive sleep apnea and central sleep apnea in the form of Cheyne-Stokes respiration in heart failure is generally high. With increasing heart failure, an increase in central sleep apnea is to be expected. While obstructive sleep apnea is regarded as an independent cardiovascular risk factor, the central sleep apnea with Cheyne-Stokes respiration, seems to be rather a symptom of heart failure, which reflects the degree of heart failure. Pathophysiologically the activation of the sympathetic nervous system and the repetitive oxygen desaturations contribute most to adversely affecting the cardiac function. The Continuous Positive Airway Pressure therapy (CPAP) is the treatment of choice for obstructive sleep apnea. Concerning the treatment of central sleep apnea and Cheyne-Stokes respiration, the adaptive servo ventilation (ASV) is currently recommended. Sự phổ biến của rối loạn hô hấp liên quan đến giấc ngủ dưới dạng ngưng thở tắc nghẽn cũng như ngưng thở trung tâm khi ngủ đặc biệt là trong dạng thở Cheyne-Stokes ở bệnh nhân suy tim nói chung là cao. Sự gia tăng suy tim thì thông thường cùng đi kèm với sự gia tăng ngưng thở trung tâm khi ngủ. Trong khi ngưng thở tắc nghẽn khi ngủ được coi là một yếu tố nguy cơ tim mạch độc lập, thì ngưng thở trung tâm khi ngủ với dạng thở Cheyne-Stokes là một biểu hiện của triệu chứng suy tim, phản ánh mức độ suy tim. Sinh lý bệnh học cơ bản là sự kích hoạt hệ thống thần kinh giao cảm và giảm oxy lặp đi lặp lại gây ảnh hưởng xấu đến chức năng tim. Liệu pháp thở áp suất dương liên tục (CPAP) là điều trị lựa chọn cho ngưng thở tắc nghẽn khi ngủ. Liệu pháp điều trị hiện nay được khuyến cáo cho điều trị ngưng thở trung tâm khi ngủ và thở dạng Cheyne-Stokes là dạng thở máy đáp ứng thông khí tự động (adaptive servo ventilation). Clinically important drug interactions in cardiovascular therapy Prof. Dr. Hans-F. Voehringer, DRK Clinics Berlin, Germany Current clinical practice in Europe for management of atrial fibrillation Prof. Dr. Hans-F. Voehringer, DRK Clinics Berlin, Germany Atrial fibrillation (AF), the most common irregular heart rhythm, is a major factor for thromboembolic stroke and its prevalence is growing worldwide. The risk of ischemic stroke or thromboembolism is 4 to 5 times higher in patients with AF, with similar risks seen both in patients with paroxysmal as well as permanent AF. Approximately every fifth stroke is caused by thromboembolism secondary to AF and strokes related to AF tend to lead to more severe disability than strokes of other etiologies. The presence of AF is independently associated with a doubling of mortality rates (Lip, 2014). Based upon these statistic numbers the management of AF is of utmost importance. In the session data are presented from a series of surveys conducted to enhance the understanding of clinical practice patterns in the treatment of AF in the member countries of the European Society of Cardiology (ESC). Faculty: PD Dr. Wolfgang Fehske, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany Dr. Birgit Gerecke, MVZ Ambulatory Cardiac Centre Peine, Germany Prof. Dr. Si Huyen Nguyen, Vietnamese German Faculty of Medicine at the Pham Ngoc Thach University of Medicine /HCM City, Academic Hospital HELIOS St. Marienberg Helmstedt, Germany Dr. Dinh Quang Nguyen, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany Prof. Dr. Hans-F. Voehringer, DRK Clinics Berlin, Germany Ehrenplakette für Professor Dr. med. Rolf Engberding und Dr. med. Si Huyen Nguyen Braunschweig. Am 12. November 2014 wurde Professor Dr. med. Rolf Engberding aus Wolfsburg und Dr. med. Si Huyen Nguyen aus Helmstedt die Ehrenplakette der Ärztekammer Niedersachsen (ÄKN) von dem Vorsitzenden der ÄKN-Bezirksstelle Braunschweig, Dr. med. Hubert Binkhoff, überreicht. Die Ehrenplakette der ÄKN wird solchen Ärzten überreicht, die sich über die alltägliche ärztliche Tätigkeit hinaus in besonderem Maße für die niedersächsische Ärzteschaft verdient gemacht haben. Dr. Nguyen und Professor Engberding sind geeignete Adressaten für die Verleihung der Ehrenplakette - sie haben sich über viele Jahre ehrenamtlich in hervorragender Weise für den Ruf und das Ansehen der deutschen Medizin eingesetzt und sich verdient gemacht. Beide Mediziner haben sich seit 1997 maßgeblich in der kontinuierlichen Ausbildung junger vietnamesischer Ärzte sowohl im Rahmen jährlich stattfindender Ausbildungstätigkeiten in städtischen und ländlichen Gebieten Vietnams als auch in der Ausbildung in deutschen Herzkatheterlaboren verdient gemacht. Ein weiterer Schwerpunkt war die Gründung der Akademie zur Förderung der wissenschaftlichen Zusammenarbeit vietnamesischer und deutscher Kardiologen und Herzchirurgen. Ferner sind Dr. Nguyen und Professor Engberding Gründungsmitglieder des 1997 gegründeten Deutsch-Vietnamesischen Förderkreises für Kardiologie e.V. (DVFK). Der DVFK ist ein gemeinnütziger Verein. Zweck des Förderkreises ist die Förderung von Gesundheitsprojekten zur Erforschung, Verhütung und Bekämpfung kardiovaskulärer Erkrankungen in Zusammenarbeit mit vietnamesischen Ärzten. Erklärtes Ziel dieser Zusammenarbeit ist es, die Völkerverständigung und Freundschaft unter den deutschen und vietnamesischen Ärzten zu fördern und zu festigen. Der Satzungszweck wird insbesondere durch die Durchführung wissenschaftlicher Veranstaltungen, Vergabe von Stipendien zur Förderung junger medizinischer Wissenschaftler, Förderung und Pflege der Zusammenarbeit im Sinne der Völkerverständigung und Freundschaft zwischen deutschen und vietnamesischen Medizinern verwirklicht. Niedersächsisches Ärzteblatt 01/2015 http://www.haeverlag.de/nae/n_beitrag.php?id=4692 Zur weiteren Information: https://www.wolfsburger-nachrichten.de/wolfsburg/doerfer/article151661995/Ehrenplakette-fuer-verdiente-Aerzte.html |
Archiv
November 2019
|